Tepezza: A New Treatment for Thyroid Eye Disease
Thyroid Eye Disease (TED) is an autoimmune condition affecting approximately 1% of adults. TED is characterized by increased tissue volume surrounding the eyes. Symptoms initially include dryness and irritation, but can evolve to include double vision and even...
New Patch for Treatment of Dementia associated with Alzheimer’s Disease
Dementia is a broad term for a group of symptoms including difficulties with memory, language, problem-solving, and other thinking skills. There are many causes of dementia, but the most common cause is Alzheimer’s Disease (AD), making up about 60-80% of cases....
FDA Approves First Generic Symbicort Inhaler
On March 15th, 2022, the FDA announced that a generic for the brand name inhaler Symbicort was approved for use in the United States. This marks a huge step forward in making inhalers for people with asthma or Chronic Obstructive Pulmonary Disease (COPD) more...
Restasis for Dry Eyes – Finally Generic!
Restasis (Cyclosporine Ophthalmic Emulsion) 0.05% was released by Allergan in 2003 for the treatment of dry eye disease. For the last 20 years, Restasis has been available as brand name only, until now. In February 2022, the FDA approved the first generic version of...
